Filing Details

Accession Number:
0001213900-20-006079
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-12 11:03:26
Reporting Period:
2020-03-11
Accepted Time:
2020-03-12 11:03:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
811641 Immucell Corp ICCC In Vitro & In Vivo Diagnostic Substances (2835) 010382980
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1384044 Scott David Tomsche C/O Immucell Corporation
56 Evergreen Drive
Portland ME 04103
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.10 Per Share Acquisiton 2020-03-11 4,600 $4.28 85,519 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. (1) This figure includes 6,092 shares of common stock held by immediate family members of Dr. Tomsche.